These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23218778)

  • 1. Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors.
    Kono M; Matsumoto T; Kawamura T; Nishimura A; Kiyota Y; Oki H; Miyazaki J; Igaki S; Behnke CA; Shimojo M; Kori M
    Bioorg Med Chem; 2013 Jan; 21(1):28-41. PubMed ID: 23218778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors.
    Kono M; Matsumoto T; Imaeda T; Kawamura T; Fujimoto S; Kosugi Y; Odani T; Shimizu Y; Matsui H; Shimojo M; Kori M
    Bioorg Med Chem; 2014 Feb; 22(4):1468-78. PubMed ID: 24440478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase.
    Keith JM; Apodaca R; Xiao W; Seierstad M; Pattabiraman K; Wu J; Webb M; Karbarz MJ; Brown S; Wilson S; Scott B; Tham CS; Luo L; Palmer J; Wennerholm M; Chaplan S; Breitenbucher JG
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4838-43. PubMed ID: 18693015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors.
    Gustin DJ; Ma Z; Min X; Li Y; Hedberg C; Guimaraes C; Porter AC; Lindstrom M; Lester-Zeiner D; Xu G; Carlson TJ; Xiao S; Meleza C; Connors R; Wang Z; Kayser F
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2492-6. PubMed ID: 21392988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure based design of novel irreversible FAAH inhibitors.
    Wang JL; Bowen SJ; Schweitzer BA; Madsen HM; McDonald J; Pelc MJ; Tenbrink RE; Beidler D; Thorarensen A
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5970-4. PubMed ID: 19765986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
    Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase.
    Keith JM; Hawryluk N; Apodaca RL; Chambers A; Pierce JM; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Scott BP; Wilson SJ; Luo L; Wennerholm ML; Chang L; Rizzolio M; Chaplan SR; Breitenbucher JG
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1280-4. PubMed ID: 24513048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH).
    Johnson DS; Ahn K; Kesten S; Lazerwith SE; Song Y; Morris M; Fay L; Gregory T; Stiff C; Dunbar JB; Liimatta M; Beidler D; Smith S; Nomanbhoy TK; Cravatt BF
    Bioorg Med Chem Lett; 2009 May; 19(10):2865-9. PubMed ID: 19386497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperidinyl thiazole isoxazolines: A new series of highly potent, slowly reversible FAAH inhibitors with analgesic properties.
    Pember SO; Mejia GL; Price TJ; Pasteris RJ
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2965-2973. PubMed ID: 27130358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas.
    Palermo G; Branduardi D; Masetti M; Lodola A; Mor M; Piomelli D; Cavalli A; De Vivo M
    J Med Chem; 2011 Oct; 54(19):6612-23. PubMed ID: 21830831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).
    Timmons A; Seierstad M; Apodaca R; Epperson M; Pippel D; Brown S; Chang L; Scott B; Webb M; Chaplan SR; Breitenbucher JG
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2109-13. PubMed ID: 18289847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of a novel, potent, selective, and orally active fatty acid amide hydrolase inhibitor, PKM-833 [(R)-N-(pyridazin-3-yl)-4-(7-(trifluoromethyl)chroman-4-yl)piperazine-1-carboxamide] in rats: Potential for the treatment of inflammatory pain.
    Endo T; Takeuchi T; Maehara S
    Pharmacol Res Perspect; 2020 Apr; 8(2):e00569. PubMed ID: 32101384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist.
    Hong Q; Bakshi RK; Palucki BL; Park MK; Ye Z; He S; Pollard PG; Sebhat IK; Liu J; Guo L; Cashen DE; Martin WJ; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Strack AM; Fong TM; MacIntyre DE; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2330-4. PubMed ID: 21439820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolites.
    Tichenor MS; Keith JM; Jones WM; Pierce JM; Merit J; Hawryluk N; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Wilson SJ; Wennerholm ML; Woestenborghs F; Beerens D; Luo L; Brown SM; Boeck MD; Chaplan SR; Breitenbucher JG
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7357-62. PubMed ID: 23141911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels.
    Ortar G; De Petrocellis L; Moriello AS; Allarà M; Morera E; Nalli M; Di Marzo V
    Bioorg Med Chem Lett; 2013 Jan; 23(1):138-42. PubMed ID: 23206861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
    Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
    Morera E; De Petrocellis L; Morera L; Moriello AS; Ligresti A; Nalli M; Woodward DF; Di Marzo V; Ortar G
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6806-9. PubMed ID: 19875281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors.
    Gur Maz T; Turanlı S; Caliskan HB; Çalışkan B; Banoglu E
    Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200082. PubMed ID: 35500130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation.
    Jaiswal S; Tripathi RKP; Ayyannan SR
    Biomed Pharmacother; 2018 Nov; 107():1611-1623. PubMed ID: 30257379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
    Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
    J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.